Related Experiment Videos

Phosphorylated 350 kD protein in the nucleus as it is associated with cell transformation

Insights

Phosphorylation of a 350 kD protein shifts its location to the nucleus in cancer cells, indicating its role in oncogenesis. This transformation-related nuclear antigen is a potential target for cancer therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Protein kinases are crucial in cell signaling and cancer development.
  • Intranuclear phosphorylation events linked to cell transformation remain poorly understood.

Purpose of the Study:

  • To investigate the role of intranuclear protein phosphorylation in cell transformation.
  • To identify novel transformation-related nuclear antigens.

Main Methods:

  • Immunoprecipitation of 32P-phosphorylated 350 kD protein from isolated nuclei.
  • Immunofluorescent staining using a monoclonal antibody against the phosphorylated site.
  • Analysis of protein localization in normal and transformed cells throughout the cell cycle.

Main Results:

  • Identified cell cycle-dependent phosphorylation of a 350 kD cytoskeleton-associated protein.
  • Observed a shift in the protein's localization from cytoplasmic/nuclear exchange in normal cells to persistent intranuclear presence in transformed cells.
  • Demonstrated that temperature-sensitive viral oncogenes and transforming growth factors induce intranuclear localization of the phosphorylated 350 kD protein.

Conclusions:

  • The 350 kD protein is a nuclear target of protein kinases activated by growth factors or oncogenes.
  • The phosphorylated 350 kD protein represents a new transformation-related nuclear antigen.
  • This finding offers insights into molecular mechanisms of oncogenesis and potential therapeutic targets.

Related Concept Videos